Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Mitogen-activated protein kinase 14 | ||
Ligand | BDBM50524520 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | ChEMBL_1893918 (CHEMBL4395839) | ||
IC50 | 38±n/a nM | ||
Citation | Heider, F; Ansideri, F; Tesch, R; Pantsar, T; Haun, U; Döring, E; Kudolo, M; Poso, A; Albrecht, W; Laufer, SA; Koch, P Pyridinylimidazoles as dual glycogen synthase kinase 3?/p38? mitogen-activated protein kinase inhibitors. Eur J Med Chem175:309-329 (2019) [PubMed] Article | ||
More Info.: | Get all data from this article, Assay Method | ||
Mitogen-activated protein kinase 14 | |||
Name: | Mitogen-activated protein kinase 14 | ||
Synonyms: | CSAID-binding protein | CSBP | CSBP1 | CSBP2 | CSPB1 | Cytokine suppressive anti-inflammatory drug-binding protein | MAP kinase 14 | MAP kinase MXI2 | MAP kinase p38 alpha | MAPK 14 | MAPK14 | MAX-interacting protein 2 | MK14_HUMAN | MXI2 | Mitogen-activated protein kinase p38 alpha | SAPK2A | Stress-activated protein kinase 2a | p38 MAP kinase alpha/beta | ||
Type: | Serine/threonine-protein kinase | ||
Mol. Mass.: | 41286.76 | ||
Organism: | Homo sapiens (Human) | ||
Description: | Q16539 | ||
Residue: | 360 | ||
Sequence: |
| ||
BDBM50524520 | |||
n/a | |||
Name | BDBM50524520 | ||
Synonyms: | CHEMBL4435922 | ||
Type | Small organic molecule | ||
Emp. Form. | C20H18ClFN4OS | ||
Mol. Mass. | 416.9 | ||
SMILES | CSc1nc(c([nH]1)-c1ccnc(NC(=O)[C@H]2C[C@H](Cl)C2)c1)-c1ccc(F)cc1 |r,wU:15.15,wD:17.18,(60.15,-5.52,;59.38,-6.85,;57.85,-6.86,;57.09,-5.51,;55.58,-5.82,;55.4,-7.35,;56.8,-7.99,;54.07,-8.1,;52.74,-7.31,;51.4,-8.07,;51.38,-9.61,;52.72,-10.39,;52.7,-11.93,;54.03,-12.71,;54.02,-14.25,;55.37,-11.95,;55.77,-10.47,;57.26,-10.88,;58.6,-10.12,;56.85,-12.37,;54.05,-9.63,;54.45,-4.78,;54.79,-3.28,;53.66,-2.23,;52.19,-2.69,;51.05,-1.65,;51.85,-4.21,;52.99,-5.24,)| | ||
Structure |